Two virtual pediatric mental health startups are scaling fast, backed by fresh funding and a shared belief that quality care — not just access — is the real fix. Handspring Health raised $19M in a Series B, while InStride Health closed a $30M Series C, both expanding insurance-based, evidence-driven therapy for kids and teens. Together, they signal a maturing market where payers are demanding proof that mental health spending actually works.
The pediatric mental health space is heating up, with two virtual startups securing major funding rounds built on a shared thesis: access to therapy is only half the battle — quality and outcomes are what matter most. Handspring Health closed a $19M Series B (led by RPS Ventures), bringing its total raised to $37M, while InStride Health landed a $30M Series C (led by Echo Health Ventures and FMZ Ventures). Both companies offer insurance-based, evidence-driven virtual care for children, teens, and young adults struggling with anxiety, depression, OCD, ADHD, and trauma.
What sets these models apart is their clinician-first approach. Handspring employs (rather than contracts) therapists and mandates in-house training in CBT, DBT, and exposure therapy — addressing a well-documented gap where most practicing therapists don't consistently use evidence-based methods. InStride, spun out of McLean Hospital, pairs each patient with a psychiatrist, therapist, and exposure coach, with AI tools supporting — not replacing — clinical decision-making.
By the Numbers:
Why it matters: Insurers are shifting from simply paying for mental health access to demanding measurable outcomes — and these startups were built for exactly that moment. As consolidation accelerates in the space, models that can prove clinical effectiveness at scale are poised to lead.
